Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone

Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone

Introduction. Due to increase in the frequency of detecting cases of tuberculosis caused by strains of mycobacteria with resistance not only to traditional, but also recently introduced into clinical circulation anti-tuberculosis drugs, it is urgent to search for and develop new drugs that can be ef...

Full description

Saved in:
Bibliographic Details
Main Authors: V. G. Nesterenko, R. N. Bolgarin, B. A. Rudoy, D. K. Salakhetdinov, Yu. G. Kazaishvili, V. S. Scherbakova, N. A. Nikitina, Yu. V. Medvedev, E. N. Fisher, E. A. Malashenko, I. E. Shohin
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-08-01
Series:Разработка и регистрация лекарственных средств
Subjects:
tuberculosis
macozinone
gastro-retentive tablet
modified release
mucoadhesion
cyclodextrin
Online Access:https://www.pharmjournal.ru/jour/article/view/999
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items